Bio-Path Holdings, Inc.(BPTH)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BPTH Bio-Path Holdings, Inc.

已收盘 11-26 16:00:00 EST

0.8045

-0.0001

-0.01%

盘后0.7722

-0.0323-4.01%

17:05 EST

最高0.8045	最低0.7600	成交量1.86万
今开0.7600	昨收0.8046	日振幅5.53%
总市值346.49万	流通市值346.35万	总股本430.69万
成交额1.45万	换手率0.43%	流通股本430.52万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"BPTH","market":"US","secType":"STK","nameCN":"Bio-Path Holdings, Inc.","latestPrice":0.8045,"timestamp":1732654800000,"preClose":0.8046,"halted":0,"volume":18599,"hourTrading":{"tag":"盘后","latestPrice":0.7722,"preClose":0.8045,"latestTime":"17:05 EST","volume":266,"amount":206.35919836,"timestamp":1732658757845},"delay":0,"floatShares":4305200,"shares":4306892,"eps":-13.740521,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.0001,"latestTime":"11-26 16:00:00 EST","open":0.76,"high":0.8045,"low":0.76,"amount":14524.67646343,"amplitude":0.055307,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-13.740521,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1732698000000},"adr":0,"adjPreClose":0.8046,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":0.7722,"preClose":0.8045,"latestTime":"17:05 EST","volume":266,"amount":206.35919836,"timestamp":1732658757845},"volumeRatio":0.432271,"impliedVol":6.8861,"impliedVolPercentile":0.9839},"requestUrl":"/m/hq/s/BPTH/wiki","defaultTab":"wiki","newsList":[{"id":"2486201009","title":"Bio-Path Holdings, Inc.盘中异动 早盘快速跳水5.54%报0.760美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486201009","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486201009?lang=zh_cn&edition=full","pubTime":"2024-11-26 22:32","pubTimestamp":1732631574,"startTime":"0","endTime":"0","summary":"北京时间2024年11月26日22时32分，Bio-Path Holdings, Inc.股票出现异动，股价快速跳水5.54%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体跌幅为0.01%。其相关个股中，Poseida Therapeutics, Inc.、Arrowhead Pharmaceuticals, Inc.、Fate Therapeutics, Inc.涨幅较大，Oncternal Therapeutics, Inc.、Poseida Therapeutics, Inc.、Cognition Therapeutics, Inc.较为活跃，换手率分别为13.41%、10.06%、8.43%，振幅较大的相关个股有Caribou Biosciences, Inc.、Cabaletta Bio, Inc.、Fate Therapeutics, Inc.，振幅分别为13.61%、13.54%、11.78%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc 是一家专注于临床和临床前阶段肿瘤学的 RNAi 纳米颗粒药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126223254a25745e0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126223254a25745e0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BPTH"],"gpt_icon":0},{"id":"2486303210","title":"Bio-Path Holdings, Inc.盘中异动 临近午盘急速跳水6.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486303210","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486303210?lang=zh_cn&edition=full","pubTime":"2024-11-26 00:30","pubTimestamp":1732552257,"startTime":"0","endTime":"0","summary":"北京时间2024年11月26日00时30分，Bio-Path Holdings, Inc.股票出现异动，股价快速下跌6.46%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体涨幅为1.79%。其相关个股中，Apollomics Inc C/Wts 01/04/2028 、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Exicure, Inc.涨幅较大，木薯科学、Cognition Therapeutics, Inc.、Exicure, Inc.较为活跃，换手率分别为121.84%、103.03%、78.40%，振幅较大的相关个股有Apollomics Inc C/Wts 01/04/2028 、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Exicure, Inc.，振幅分别为94.06%、78.65%、75.84%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc 是一家专注于临床和临床前阶段肿瘤学的 RNAi 纳米颗粒药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126003057abde3276&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126003057abde3276&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BPTH","BK4139"],"gpt_icon":0},{"id":"2485200478","title":"Bio-Path Holdings, Inc.2024财年第三财季实现净利润-2.12百万美元，同比增加33.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485200478","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485200478?lang=zh_cn&edition=full","pubTime":"2024-11-24 00:00","pubTimestamp":1732377622,"startTime":"0","endTime":"0","summary":"11月24日，Bio-Path Holdings, Inc.公布财报，公告显示公司2024财年第三财季净利润为-2.12百万美元，同比增加33.75%；其中营业收入为0.00美元，每股基本收益为-0.70美元。机构评级：截至2024年11月24日，当前有1家机构对Bio-Path Holdings, Inc.目标价做出预测，其中目标均价为12.00美元，其中最低目标价为12.00美元，最高目标价为12.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241124000042a2504563&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241124000042a2504563&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BPTH"],"gpt_icon":0},{"id":"2485269718","title":"Bio-Path Holdings, Inc.盘中异动 早盘股价大跌6.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485269718","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485269718?lang=zh_cn&edition=full","pubTime":"2024-11-22 22:31","pubTimestamp":1732285915,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日22时31分，Bio-Path Holdings, Inc.股票出现波动，股价大幅跳水6.01%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.37%。其相关个股中，Virpax Pharmaceuticals, Inc.、Exicure, Inc.、Replimune Group, Inc.涨幅较大，Virpax Pharmaceuticals, Inc.、Molecular Templates, Inc.、Exicure, Inc.较为活跃，换手率分别为516.45%、62.47%、36.75%，振幅较大的相关个股有Virpax Pharmaceuticals, Inc.、Cyclerion Therapeutics, Inc.、Exicure, Inc.，振幅分别为19.38%、14.78%、10.96%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc 是一家专注于临床和临床前阶段肿瘤学的 RNAi 纳米颗粒药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122223155a24e2071&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122223155a24e2071&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BPTH","BK4139"],"gpt_icon":0},{"id":"2485125414","title":"Bio-Path Holdings, Inc.盘中异动 大幅拉升7.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485125414","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485125414?lang=zh_cn&edition=full","pubTime":"2024-11-22 00:23","pubTimestamp":1732206220,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日00时23分，Bio-Path Holdings, Inc.股票出现波动，股价大幅拉升7.26%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.02%。其相关个股中，Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Biodexa Pharmaceuticals Plc、Pasithea Therapeutics Corp C/Wts 12/08/2026 涨幅较大，Biodexa Pharmaceuticals Plc、Conduit Pharmaceuticals Inc.、Tff Pharmaceuticals, Inc.较为活跃，换手率分别为769.91%、483.54%、118.09%，振幅较大的相关个股有Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Biodexa Pharmaceuticals Plc、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 ，振幅分别为162.20%、81.04%、76.33%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc 是一家专注于临床和临床前阶段肿瘤学的 RNAi 纳米颗粒药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122002340a24ba772&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122002340a24ba772&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BPTH"],"gpt_icon":0},{"id":"2484692350","title":"Bio-Path Holdings, Inc.盘中异动 早盘急速拉升6.65%报0.800美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484692350","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484692350?lang=zh_cn&edition=full","pubTime":"2024-11-19 22:38","pubTimestamp":1732027098,"startTime":"0","endTime":"0","summary":"北京时间2024年11月19日22时38分，Bio-Path Holdings, Inc.股票出现异动，股价快速上涨6.65%。截至发稿，该股报0.800美元/股，成交量1899股，换手率0.04%，振幅4.20%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体跌幅为0.57%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc 是一家专注于临床和临床前阶段肿瘤学的 RNAi 纳米颗粒药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111922381898e4381c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111922381898e4381c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BPTH","BK4139"],"gpt_icon":0},{"id":"2484561679","title":"Bio-Path Holdings, Inc.盘中异动 早盘快速下挫5.85%报0.765美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484561679","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484561679?lang=zh_cn&edition=full","pubTime":"2024-11-18 22:39","pubTimestamp":1731940746,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日22时39分，Bio-Path Holdings, Inc.股票出现波动，股价快速下挫5.85%。截至发稿，该股报0.765美元/股，成交量2.1121万股，换手率0.57%，振幅6.15%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.10%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc 是一家专注于临床和临床前阶段肿瘤学的 RNAi 纳米颗粒药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822390698e4340f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822390698e4340f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BPTH"],"gpt_icon":0},{"id":"2483374757","title":"Bio Path 控股公司公布截至 9 月 30 日的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2483374757","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483374757?lang=zh_cn&edition=full","pubTime":"2024-11-15 22:31","pubTimestamp":1731681097,"startTime":"0","endTime":"0","summary":"Bio Path 控股公司公布截至 9 月 30 日的季度业绩 - 收益摘要Bio Path Holdings Inc BPTH.OQ报告，截至9月30日的季度调整后每股亏损70美分，高于去年同期的每股收益6.40美元。Bio Path 控股公司本季度每股收益为亏损 70 美分。该公司当季亏损 212 万美元。Bio Path Holdings Inc 本季度股价下跌了 1.1%，今年迄今为止下跌了 90.3%。华尔街对 Bio Path Holdings Inc 的 12 个月目标价中位数为 20.00 美元。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241115:nL4T3MM15Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BPTH","BK4139"],"gpt_icon":0},{"id":"2483801389","title":"Bio-Path Holdings, Inc.盘中异动 大幅上涨5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483801389","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483801389?lang=zh_cn&edition=full","pubTime":"2024-11-15 00:34","pubTimestamp":1731602057,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日00时34分，Bio-Path Holdings, Inc.股票出现异动，股价快速拉升5.20%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体跌幅为0.50%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、Pulmatrix, Inc.、奥麦罗制药涨幅较大，Elevai Labs, Inc.、Pulmatrix, Inc.、Calidi Biotherapeutics, Inc.较为活跃，换手率分别为3006.59%、338.93%、45.83%，振幅较大的相关个股有Pulmatrix, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Abpro Holdings, Inc，振幅分别为112.92%、86.36%、79.03%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc 是一家专注于临床和临床前阶段肿瘤学的 RNAi 纳米颗粒药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111500341798e42b2f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111500341798e42b2f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BPTH","BK4139"],"gpt_icon":0},{"id":"2483985838","title":"Bio Path Holdings Inc   预计每股亏损1.02美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2483985838","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483985838?lang=zh_cn&edition=full","pubTime":"2024-11-13 23:43","pubTimestamp":1731512611,"startTime":"0","endTime":"0","summary":"   * Bio Path Holdings Inc    将于11月15日公布截至2024年9月30日的财报，预计季度营收将保持不变。*    * LSEG 的分析师平均预计 Bio Path Holdings Inc 每股亏损 1.02 美元。* 分析师对该公司股票的评级为 \"买入\"。* 华尔街对 Bio Path Holdings Inc 的 12 个月目标价中位数为 20.00 美元，高于上一交易日 0.87 美元的收盘价。11月13日 - 本摘要于北京时间 11 月 13 日 15:42 机器生成。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"Bio Path Holdings Inc   预计每股亏损1.02美元 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BPTH"],"gpt_icon":0},{"id":"2481198751","title":"Bio-Path Holdings, Inc.盘中异动 临近午盘股价大涨7.93%报0.939美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481198751","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481198751?lang=zh_cn&edition=full","pubTime":"2024-11-08 01:00","pubTimestamp":1730998831,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日01时00分，Bio-Path Holdings, Inc.股票出现异动，股价急速拉升7.93%。截至发稿，该股报0.939美元/股，成交量3.2859万股，换手率0.89%，振幅6.13%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.50%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc 是一家专注于临床和临床前阶段肿瘤学的 RNAi 纳米颗粒药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108010031971a527a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108010031971a527a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BPTH","BK4139"],"gpt_icon":0},{"id":"2480005370","title":"Bio-Path Holdings, Inc.盘中异动 快速跳水5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480005370","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480005370?lang=zh_cn&edition=full","pubTime":"2024-11-01 00:22","pubTimestamp":1730391770,"startTime":"0","endTime":"0","summary":"北京时间2024年11月01日00时22分，Bio-Path Holdings, Inc.股票出现异动，股价急速下跌5.16%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体跌幅为3.40%。其相关个股中，Tc Biopharm  Plc C/Wts 10/02/2028 、Ocean Biomedical Inc C/Wts 14/02/2028 、Exicure, Inc.涨幅较大，Aditxt, Inc.、Evogene Ltd.、Gri Bio, Inc.较为活跃，换手率分别为257.25%、235.62%、179.62%，振幅较大的相关个股有Vaccinex, Inc.、180 Life Sciences Corp C/Wts 07/11/2025、Gri Bio, Inc.，振幅分别为47.15%、46.15%、45.95%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc 是一家专注于临床和临床前阶段肿瘤学的 RNAi 纳米颗粒药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101002250971a39b4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101002250971a39b4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BPTH","BK4139"],"gpt_icon":0},{"id":"2479788170","title":"Bio-Path Holdings, Inc.盘中异动 早盘急速跳水5.66%报1.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479788170","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479788170?lang=zh_cn&edition=full","pubTime":"2024-10-30 21:31","pubTimestamp":1730295070,"startTime":"0","endTime":"0","summary":"北京时间2024年10月30日21时31分，Bio-Path Holdings, Inc.股票出现波动，股价急速下跌5.66%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体跌幅为0.30%。其相关个股中，Tharimmune, Inc.、Ensysce Biosciences, Inc.、Biovie Inc.涨幅较大，Tharimmune, Inc.、Ensysce Biosciences, Inc.、Gri Bio, Inc.较为活跃，换手率分别为1620.15%、96.94%、13.89%，振幅较大的相关个股有Tharimmune, Inc.、Cormedix Inc.、Dogwood Therapeutics, Inc.，振幅分别为19.21%、8.86%、6.95%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc 是一家专注于临床和临床前阶段肿瘤学的 RNAi 纳米颗粒药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103021311095bd8dc6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103021311095bd8dc6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BPTH"],"gpt_icon":0},{"id":"2477136160","title":"Bio-Path Holdings, Inc.盘中异动 股价大涨5.61%报1.13美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477136160","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477136160?lang=zh_cn&edition=full","pubTime":"2024-10-23 02:27","pubTimestamp":1729621668,"startTime":"0","endTime":"0","summary":"北京时间2024年10月23日02时27分，Bio-Path Holdings, Inc.股票出现异动，股价大幅拉升5.61%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体跌幅为0.97%。其相关个股中，Ensysce Biosciences, Inc.、Genprex, Inc.、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 涨幅较大，Genprex, Inc.、Ensysce Biosciences, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为5525.90%、4986.46%、2140.56%，振幅较大的相关个股有Ensysce Biosciences, Inc.、Genprex, Inc.、Aptevo Therapeutics Inc.，振幅分别为189.27%、101.99%、99.41%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc 是一家专注于临床和临床前阶段肿瘤学的 RNAi 纳米颗粒药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241023022748ab6c4805&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241023022748ab6c4805&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BPTH"],"gpt_icon":0},{"id":"2476171233","title":"Bio-Path Holdings, Inc.盘中异动 早盘快速下跌5.17%报1.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2476171233","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476171233?lang=zh_cn&edition=full","pubTime":"2024-10-17 22:34","pubTimestamp":1729175680,"startTime":"0","endTime":"0","summary":"北京时间2024年10月17日22时34分，Bio-Path Holdings, Inc.股票出现波动，股价快速下跌5.17%。截至发稿，该股报1.10美元/股，成交量3.0784万股，换手率1.21%，振幅4.87%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.83%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc 是一家专注于临床和临床前阶段肿瘤学的 RNAi 纳米颗粒药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241017223440ab6adb0f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241017223440ab6adb0f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BPTH"],"gpt_icon":0},{"id":"2475787684","title":"Bio-Path Holdings, Inc.盘中异动 早盘大幅下挫7.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2475787684","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475787684?lang=zh_cn&edition=full","pubTime":"2024-10-15 22:08","pubTimestamp":1729001312,"startTime":"0","endTime":"0","summary":"北京时间2024年10月15日22时08分，Bio-Path Holdings, Inc.股票出现波动，股价大幅下跌7.07%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.02%。其相关个股中，60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Apollomics Inc C/Wts 01/04/2028 、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Bright Minds Biosciences Inc.、Lipella Pharmaceuticals Inc.、Enveric Biosciences, Inc.较为活跃，换手率分别为637.06%、286.51%、177.99%，振幅较大的相关个股有Bright Minds Biosciences Inc.、Apollomics Inc C/Wts 01/04/2028 、Gritstone Bio, Inc.，振幅分别为99.20%、79.69%、33.15%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc 是一家专注于临床和临床前阶段肿瘤学的 RNAi 纳米颗粒药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241015220833ab6a46e1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241015220833ab6a46e1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BPTH","BK4139"],"gpt_icon":0},{"id":"2475362083","title":"Bio-Path Holdings, Inc.盘中异动 早盘急速下挫5.31%报1.07美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2475362083","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475362083?lang=zh_cn&edition=full","pubTime":"2024-10-14 21:31","pubTimestamp":1728912691,"startTime":"0","endTime":"0","summary":"北京时间2024年10月14日21时31分，Bio-Path Holdings, Inc.股票出现波动，股价急速跳水5.31%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.08%。其相关个股中，Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Tevogen Bio Holdings Inc.、Longboard Pharmaceuticals, Inc.涨幅较大，Aditxt, Inc.、Virpax Pharmaceuticals, Inc.、Rani Therapeutics Holdings, Inc.较为活跃，换手率分别为61.70%、40.73%、26.54%，振幅较大的相关个股有Mustang Bio, Inc.、Rani Therapeutics Holdings, Inc.、Inventiva Sa，振幅分别为10.45%、9.90%、7.94%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc 是一家专注于临床和临床前阶段肿瘤学的 RNAi 纳米颗粒药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101421313198e3c42e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101421313198e3c42e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BPTH"],"gpt_icon":0},{"id":"2474744811","title":"Bio-Path Holdings, Inc.盘中异动 股价大涨5.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474744811","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474744811?lang=zh_cn&edition=full","pubTime":"2024-10-10 22:07","pubTimestamp":1728569223,"startTime":"0","endTime":"0","summary":"北京时间2024年10月10日22时07分，Bio-Path Holdings, Inc.股票出现异动，股价大幅拉升5.45%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体跌幅为0.68%。其相关个股中，Tc Biopharm  Plc C/Wts 10/02/2028 、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Cingulate Inc C/Wts 10/12/2026 涨幅较大，Aditxt, Inc.、Tempest Therapeutics, Inc.、Clearmind Medicine Inc.较为活跃，换手率分别为227.11%、131.15%、104.96%，振幅较大的相关个股有Genenta Science Spa、Briacell Therapeutics Corp C/Wts 24/02/2025、Tc Biopharm  Plc C/Wts 10/02/2028 ，振幅分别为25.48%、21.79%、20.50%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc 是一家专注于临床和临床前阶段肿瘤学的 RNAi 纳米颗粒药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101022070398e3bbcf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101022070398e3bbcf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BPTH"],"gpt_icon":0},{"id":"2473947559","title":"Bio-Path Holdings, Inc.股价拉升50.32% 市值涨164.53万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2473947559","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473947559?lang=zh_cn&edition=full","pubTime":"2024-10-08 21:30","pubTimestamp":1728394203,"startTime":"0","endTime":"0","summary":"北京时间2024年10月08日21时30分，Bio-Path Holdings, Inc.股票出现异动，股价大幅拉升50.32%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Bio-Path Holdings, Inc.、Klotho Neurosciences, Inc.、Fractyl Health, Inc.涨幅较大，Virios Therapeutics, Inc.、Aditxt, Inc.、Bio-Path Holdings, Inc.较为活跃，换手率分别为2598.25%、1602.51%、1045.59%，振幅较大的相关个股有Oragenics Inc.、Nanoviricides, Inc.、Ibio, Inc.，振幅分别为12.43%、5.11%、1.50%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc 是一家专注于临床和临床前阶段肿瘤学的 RNAi 纳米颗粒药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241008213004a1df0dec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241008213004a1df0dec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BPTH"],"gpt_icon":0},{"id":"2472379728","title":"Bio-Path Holdings, Inc.盘中异动 快速下跌5.48%报0.860美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472379728","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472379728?lang=zh_cn&edition=full","pubTime":"2024-10-01 22:04","pubTimestamp":1727791469,"startTime":"0","endTime":"0","summary":"北京时间2024年10月01日22时04分，Bio-Path Holdings, Inc.股票出现波动，股价大幅下挫5.48%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体跌幅为0.16%。其相关个股中，Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 涨幅较大，Aditxt, Inc.、Silexion Therapeutics Corp、Sagimet Biosciences Inc. - Series A较为活跃，换手率分别为593.19%、531.32%、96.65%，振幅较大的相关个股有Tc Biopharm  Plc C/Wts 10/02/2028 、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Bioatla, Inc.，振幅分别为82.42%、48.90%、34.66%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc 是一家专注于临床和临床前阶段肿瘤学的 RNAi 纳米颗粒药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410012204299719db39&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410012204299719db39&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BPTH"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.biopathholdings.com","stockEarnings":[{"period":"1week","weight":0.0727},{"period":"1month","weight":-0.2685},{"period":"3month","weight":-0.288},{"period":"6month","weight":-0.5674},{"period":"1year","weight":-0.9167},{"period":"ytd","weight":-0.9131}],"compareEarnings":[{"period":"1week","weight":0.0159},{"period":"1month","weight":0.0319},{"period":"3month","weight":0.0641},{"period":"6month","weight":0.1358},{"period":"1year","weight":0.3124},{"period":"ytd","weight":0.2571}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Bio-path Holdings, Inc.正处于发展阶段，其领先的治癌药物Liposomal Grb-2目前处于临床试验阶段。该公司在得克萨斯大学的附属医院安德森癌症研究中心的技术支持下成立，在特许协议下致力于研发新的抗癌药物。其拥有用于系统反义疗法的药物传输平台技术与知识产权。该公司还计划研究脂质体肿瘤定位技术，因为这一技术可以完善目前的传输技术，能进一步提高反义疗法的有效性。除了现有的技术专利，该公司将保持与安德森研究中心主要成员的紧密合作关系，因为后者将来可能为该公司提供潜在药物。该公司还希望将其技术扩展到反义药物之外的抗癌药物，包括安德森研究中心之外的机构所提供的候选药物。该公司成立于2007年5月10日。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.055835},{"month":2,"riseRate":0.4,"avgChangeRate":0.01406},{"month":3,"riseRate":0.6,"avgChangeRate":0.683886},{"month":4,"riseRate":0.181818,"avgChangeRate":-0.127567},{"month":5,"riseRate":0.454545,"avgChangeRate":-0.053526},{"month":6,"riseRate":0.545455,"avgChangeRate":0.01417},{"month":7,"riseRate":0.272727,"avgChangeRate":-0.105842},{"month":8,"riseRate":0.272727,"avgChangeRate":-0.169267},{"month":9,"riseRate":0.181818,"avgChangeRate":-0.091013},{"month":10,"riseRate":0.545455,"avgChangeRate":0.085712},{"month":11,"riseRate":0.363636,"avgChangeRate":-0.112447},{"month":12,"riseRate":0.4,"avgChangeRate":-0.110282}],"exchange":"NASDAQ","name":"Bio-Path Holdings, Inc.","nameEN":"Bio-Path"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Bio-Path Holdings, Inc.(BPTH)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Bio-Path Holdings, Inc.(BPTH)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Bio-Path Holdings, Inc.,BPTH,Bio-Path Holdings, Inc.股票,Bio-Path Holdings, Inc.股票老虎,Bio-Path Holdings, Inc.股票老虎国际,Bio-Path Holdings, Inc.行情,Bio-Path Holdings, Inc.股票行情,Bio-Path Holdings, Inc.股价,Bio-Path Holdings, Inc.股市,Bio-Path Holdings, Inc.股票价格,Bio-Path Holdings, Inc.股票交易,Bio-Path Holdings, Inc.股票购买,Bio-Path Holdings, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Bio-Path Holdings, Inc.(BPTH)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Bio-Path Holdings, Inc.(BPTH)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}